Characterization of adrenal masses in young adults at a tertiary care academic medical center
Open Access
- 26 February 2026
- journal article
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 10 (5)
Abstract
Context: Evidence on the etiology and function of adrenal masses in younger adults is scarce. Objective: This work aimed to characterize the clinical, imaging, and biochemical presentation of adrenal masses in 18- to 40-year-olds. Methods: A retrospective cohort study was conducted January 2016 to December 2021 at a tertiary academic medical center. Participants included young adults (age 18-40 years) with adrenal masses identified through radiologic registry. Exclusion criteria included preexisting adrenal masses before 2016, hyperplasia, or masses smaller than 1 cm. Outcomes included adrenal mass diagnosis, as determined by reference standard of histopathology, radiologic surveillance, and biochemical evaluation. Results: A total of 255 patients (women 142 [56%]; White 156 [61%]; median age 35 years [interquartile range 30-39 years]) were included. Comorbidities included genetic predisposition syndromes (16, 6.3%), preexisting malignancy (70, 27%), obesity (100, 48%), hypertension (89, 35%), and diabetes (25, 10%). The majority of adrenal masses were incidentally found (184, 72%) and median size was 1.9 cm (IQR 1.4-2.7 cm) on detection. Among adrenal masses in young adults, prevalence of malignancy and pheochromocytoma was 16% and 4%, respectively; among adrenal incidentalomas, 5% were malignant. Factors associated with malignancy or pheochromocytoma in multivariable analysis included nonincidental mechanism of discovery (odds ratio [OR] 15.5; 95% CI, 7.2-35.7; P < .001), and larger size (OR 1.5; 95% CI, 1.2-2.0; P < .001). Hormonal evaluation was performed in only 57 (22%) patients and was positive for hormone hypersecretion in 16 (28%) of tested individuals. Conclusion: We demonstrated a high prevalence of malignancy and pheochromocytoma in our cohort of young adults with adrenal masses. Completion of appropriate hormonal work-up was infrequent, potentially missing patients with functioning adrenal adenomas.Keywords
Funding Information
- Clinical and Translational Science Award
- National Center for Advancing Translational Sciences
- National Institutes of Health
- Siteman Comprehensive Cancer Center
- Instituto Nacional do Câncer, Ministério da Saúde (P30 CA091842)
- Norges Idrettshøgskole
This publication has 35 references indexed in Scilit:
- Projected Lifetime Cancer Risks From Current Computed Tomography ImagingJAMA Internal Medicine, 2025
- Mortality in Patients With Nonfunctional Adrenal TumorsJAMA Internal Medicine, 2023
- American Association of Endocrine Surgeons Guidelines for AdrenalectomyJAMA Surgery, 2022
- Cortisol level after dexamethasone suppression test in patients with non-functioning adrenal incidentaloma is positively associated with the duration of reactive hyperemia response on microvascular bedJournal of Endocrinological Investigation, 2020
- Hormonal Evaluation of Incidental Adrenal Masses: The Exception, Not the RuleWorld Journal of Surgery, 2020
- Adherence to guidelines for hormonal evaluation in patients with incidentally detected adrenal nodules: effects of radiology report wording and standardized reportingAbdominal Radiology, 2020
- Management of incidental adrenal masses: an updateAbdominal Radiology, 2019
- Adrenal Incidentaloma and Adherence to International Guidelines for Workup Based on a Retrospective Review of the Type of Language Used in the Radiology ReportJournal of the American College of Radiology, 2019
- Clinical, Biochemical, and Radiological Characteristics of a Single-Center Retrospective Cohort of 705 Large Adrenal TumorsMayo Clinic Proceedings: Innovations, Quality & Outcomes, 2018
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987